Literature DB >> 11153324

Techniques to maintain a bloodless field in lower extremity surgery.

H A Tarver1, S K Oliver, G J Ramming, B Englemann.   

Abstract

PURPOSE: Most surgeons and podiatrists prefer to operate on toes and feet with a bloodless operating field. This can be achieved with a pneumatic tourniquet applied to the thigh after exsanguination of the limb with a rubber bandage or with an Esmark bandage alone, placed below the knee. A pneumatic tourniquet requires the use of general anesthesia with associated increased risks. The purpose of this study was to describe the differences in the complications in patients who have had foot surgery with either a thigh pneumatic tourniquet or a lower-leg Esmark bandage. SAMPLE: 120 patients underwent foot surgery at a 350-bed tertiary care facility in Central Texas.
DESIGN: A retrospective, descriptive study of the postoperative complications after foot surgery.
RESULTS: Based on limb assessment in the operating room and in day surgery, there were no adverse effects at the site of placement of the Esmark or the pneumatic tourniquets or unexpected postoperative problems at the surgical site. No patient expressed any problems at the site of placement of the Esmark or the pneumatic tourniquet.
CONCLUSIONS: A calf ankle Esmark with adequate padding is a safe and effective method to achieve a bloodless surgical field for foot and ankle surgery.

Entities:  

Mesh:

Year:  2000        PMID: 11153324     DOI: 10.1097/00006416-200019040-00012

Source DB:  PubMed          Journal:  Orthop Nurs        ISSN: 0744-6020            Impact factor:   0.913


  2 in total

1.  Bipolar sealer not superior to standard electrocautery in primary total hip arthroplasty: a meta-analysis.

Authors:  Yang Yang; Li-Chao Zhang; Fei Xu; Jia Li; Yong-Ming Lv
Journal:  J Orthop Surg Res       Date:  2014-10-10       Impact factor: 2.359

Review 2.  Auto-transfusion tourniquets: the next evolution of tourniquets.

Authors:  David H Tang; Bohdan T Olesnicky; Michael W Eby; Lawrence E Heiskell
Journal:  Open Access Emerg Med       Date:  2013-12-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.